Genomics-based quality control for stem cell therapy: Parkinson's Disease

Jeanne Loring, Professor, Scripps Research Institute

Video Overview

Scripps Research Institute Professor Jeanne Loring presented a summary of her lab’s efforts to employ human pluripotent stem cells as a therapy for incurable neurological disorders including Parkinson’s disease, multiple sclerosis and fragile X syndrome. Dr. Loring discusses the unpredictable but sometimes remarkable success of early fetal tissue transplants for Parkinson’s, and her optimism that sufficiently rigorous characterisation of the cell populations contributing to a positive outcome will lead within the next few years to a consistently curative therapy.